Parasitic diarrhoea in treatment-naïve HIV-positive patients attending the University of Ilorin Teaching Hospital (UITH) Highly Active Antiretroviral Treatment (HAART) Clinic by Joseph, A.A & Ano-Edward, G.H
International Journal of Medicine and Biomedical Research 
Volume 5 Issue 3 September – December 2016 
www.ijmbr.com 
© Joseph and Ano-Edward; licensee Michael Joanna Publications  
 
Original Article  Open Access 
 
 This is an Open Access article distributed under the terms of the creative commons Attribution 4.0 licence 
(http://creativecommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited. 
Parasitic diarrhoea in treatment-naïve HIV-positive  patients 
attending the University of Ilorin Teaching Hospita l (UITH) 
Highly Active Antiretroviral Treatment (HAART) Clin ic 
 
Joseph A.A1*, Ano-Edward G.H2 
 
1Department of Medical Microbiology and Parasitology, College of Health Sciences, Bowen 
University Iwo, Osun State, Nigeria.2Department of Anatomic Pathology, College of health 
sciences, Bowen University, Iwo, Osun State, Nigeria. 
 
*Corresponding author: adejokejoseph2012@gmail.com 
 




HIV is a global public health issue and a 
serious health and development challenge.[1] 
“Since 2000, 38.1 million people have become 
infected with HIV and 25.3 million people have 
died of AIDS-related illnesses”.[2] Currently, 
about 34 million people live with HIV.[1] About 
25.8 million cases are in sub-Saharan Africa, 
accounting for 70% of the global total.[2] Only 
54% of all People Living With HIV/AIDS 




Background:  HIV is a public health issue with diarrhoea being the commonest 
gastrointestinal symptom especially in individuals with lower CD4+ cell counts. Most 
times, parasitic infections present as diarrhoea. Depending on geographical location, 
the pathogens responsible for diarrhoea vary. Aim:  To relate the degree of 
immunodeficiency in HIV-infected patients to diarrhoea as a result of infestation by 
parasitic agent. Methods:  250 HIV positive and 250 HIV negative participants were 
recruited. Stool and blood samples were taken from all participants. Macroscopic and 
microscopic examinations of the stool were done while CD4+ count was estimated 
from the blood sample collected. Wet preparation of stool sample was done and 
concentrated stool was used for modified Ziehl Neelsen staining. Results: Diarrhoea 
was present in 200 participants, 118 of which were among the HIV positive group. 
Parasites were demonstrated in 82.3% of the test participants with diarrhoea and 
17.7% of the controls with diarrhoea. Of the HIV positive with diarrhoea, 70.3% had a 
CD4 <200 cells/µl and 29.7% had a CD4 of 200-500cells/µl. Parasites in both groups 
were Ascaris lumbricoides, Balantidium coli, Entamoeba histolytica, Schistosoma 
mansoni, Hookworm, Strongyloides stercoralis and coccidian parasites though at 
varying frequencies. Of the 79 with parasites, 60 had single parasitosis, while 19 had 
multiple parasitosis. CD4 count was the only variable that correctly predicts presence 
of diarrhoea. Conclusion : Diarrhoea associated with parasitic infection HIV patients is 
a function of the immune status of the individual. 
Key words:  People Living with HIV/AIDS (PLWHA), HIV/AIDS, diarrhoea, intestinal 
parasite, HAART NAÏVE, immunosuppression 
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Primarily, HIV affects people in their most 
productive period, and 50% of new infections 
are among those less than 25 years.[4] Many of 
the countries that are hardest hit by HIV also 
suffered from other infectious diseases. A 
major health problem among HIV seropositive 
patients is superimposed infection due to the 
defect of immunity. The primary site of disease 
in HIV infection remains the gastrointestinal 
(GI) tract.[5] About 50% of HIV-infected patients 
have GI symptoms, and most of them develop 
GI complications.[6] Diarrhoea is the 
commonest GI symptom in HIV-positive 
patients.[7] The prevalence of diarrhoea among 
outpatients has been reported to range from 
0.9 to 14%.[8,9] The prevalence of HIV has 
been shown to be more among homosexual 
men and individuals with lower CD4+ cell 
counts.[10]This is likely because it has been 
reported that risk of transmitting HIV from anal 
intercourse is significantly higher than vaginal. 
The rate ranges from 0.04 to 0.38% per act for 
female-to-male transmission in low and high 
income countries respectively, 0.08 to 0.30% 
per act for male to female transmission in low 
and high income countries, compared to 1.4 to 
1.7% per act in anal transmission.[11,12] The 
pathogenesis of HIV/AIDS is associated with 
decline in T-lymphocytes, which has CD4 
receptors.[13,14] “The end point therefore is the 
subsequent depletion of CD4+ T lymphocytes 
leading to a failure of both the cellular and the 
humoral aspects of the body's immunity with 
significant morbidity and mortality, as seen 
through the natural course of the disease”.[15] 
 
In hospitalized individuals with advanced HIV 
infection, up to 50% have diarrhea.[8] There is 
however significant geographic variation in the 
prevalence of diarrhoea and the spectrum of 
enteric pathogens.[16] Pathogens were 
identified in more than 50% of patients with 
advanced HIV and diarrhea.[17,18] In several 
studies, co-infections were common, 
emphasizing the importance of ruling out all 
pathogens thoroughly when evaluating 
diarrhoea.[19] Studies have  demonstrated a 
varying clinical spectrum of diarrhoea, with 
pathogen-negative diarrhoea now representing 
the majority of patients.[20,21] Other studies 
have reported a dramatic decrease in 
cryptosporidial diarrhoea over the past 5 
years.[8] 
 
Literature search indicate that parasitic 
infections often manifest as diarrhoea and that 
significant disease have been recorded in 50–
96% of cases with 90% prevalence rate 
reported in Africa.[22]Various species of 
protozoa have been implicated in acute and 
chronic diarrhoea in HIV/AIDS; namely 
Cryptosporidium parvum, Isospora belli, 
Microsporidium species, Entamoeba 
histolytica/Entamoeba dispar, Giardia 
intestinalis.[23] Intestinal parasites are endemic 
in many regions of the world where HIV/AIDS 
is also prevalent.[24] Sub-Saharan Africa where 
Nigeria is located is among the regions where 
intestinal parasitic infections is entrenched and 
the largest burden of AIDS cases exist.[25] 
 
It has been reported that infective causes of 
chronic diarrhoea can be easily diagnosed with 
satisfactory response to treatment except 
cryptosporidiosis and HIV-related 
enteropathy.[26] To ensure adequate 
management guidelines for HIV/AIDS, its 
prevalence by laboratory diagnostic measures 
are required since there is a geographical 
variation in the pathogens responsible 
diarrhoea in HIV/AIDS patients.[22] 
 
Medications such as protease inhibitors, 
including nelfinavir and saquinavir, are 
common cause of diarrhoea in the early stage 
of HIV. This form of diarrhoea is usually self-
limiting, lasting less than 2 to 4 weeks. 
However, chronic diarrhoea may be seen even 
in patients with improved CD4 cell count and 
decreased viral load.[27] Other aetiologies of 
diarrhoea include idiopathic colitis, 
enteropathogenic Escherichia coli, and small 
bowel bacterial overgrowth.[27] Some studies 
have suggested that HIV may be a diarrhoeal 
pathogen since viral proteins are found in the 
gut and the virus has been identified in 
histologic specimens from the GI tract tissue in 
about 40% of patients; confined to lamina 
propria macrophages and enterochromaffin 
cells.[8] “Intestinal HIV infection may also affect 
local humoral immunity and cause motility 
disturbances via effects on autonomic 
nerves”.[15,28,29,30] 
 
“An ‘idiopathic AIDS enteropathy’ has been 
proposed to account for the diarrhoea in HIV-
infected patients who lack an identifiable 
pathogen”.[8] This is probably due to the 
indirect effects of HIV on enteric 
homeostasis.[8] Though the manifestations is 
still controversial, the term denotes a chronic 
diarrhoeal illness with no identified aetiology in 
patients with advanced HIV disease.[8] Some 
reports suggest the inclusion of mucosal 
hypoproliferation as a defining feature while 
others reported that enteric HIV infection may 
cause mucosal atrophy, which impairs 
absorption in the small intestine with 
consequent diarrhoea and weight loss.[8] 
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About 9% of PLWHA live in Nigeria.[2] Though 
HIV prevalence among Nigerian adults is 
significantly low (3.2%) when compared with 
other sub-Saharan African countries such as 
South Africa (19.1%) and Zambia (12.5%),[31] 
about 3.2 million people were reported to have 
HIV in 2013 in Nigeria.[32] “Nigeria, together 
with South Africa and Uganda, account for 
almost 50% of all annual new HIV infections in 
sub-Saharan Africa”.[33,34] In addition, about 
210,000 people died of AIDS-related illnesses 
in Nigeria in 2013, which is about 14% of the 
world total.[34] The major cause of morbidity 
and mortality in the HIV infected, and also the 
most prevalent symptom patient present with 
is diarrhoea. Since there is a geographic 
variation in the prevalence of diarrhoea and 
the spectrum of enteric pathogens implicated, 
the need to evaluate extensively the 
prevalence and the likely pathogens that 
causes of this symptom in this population, in 
this geographical location is pertinent.  
 
The study is aimed at examining the 
relationship between the degree of 
immunodeficiency in HIV infected patients 
using CD4 count and diarrhoea as a result of 




The University of Ilorin Teaching Hospital 
where the study was carried out serves as a 
referral hospital to surrounding states including 
Niger, Kogi, Oyo, Ekiti, Ondo and Osun states. 
The hospital runs a Highly Active Antiretroviral 
Therapy (HAART) clinic supported previously 
by the Institute Of Human Virology, Nigeria 
(IHVN), but now supported by Management 
Science for Health (MSH) as at the time of this 
study. The clinic was established on 
September 3rd, 2008 and the total number of 
enrolee as at time of study was5433 made up 
of 1885 adult males, 2874 adult females, 329 
paediatric males and 345 paediatric female 
patients. Of the adult enrolees, 1498 have 
been commenced on antiretroviral drug.[35] 
 
Sample size when studying proportions with 
population less than ten thousand (10,000) 





where nf - the desired sample size when 
population is less than 10,000 
 n - the desired sample size when the 
population is more than 10,000 
N - the estimate of the population size. it is 
total adult population minus population on 
drugs. 
N= (2874+1885) – 1498 = 3261 
 
n can be calculated using the formula 
  n= Z2pq / d2        
where n= desired sample size when 
population is greater than 10,000 
           z= standard normal deviate, usually set 
at 1.96, which corresponds to the 95th 
confidence level 
           p= proportion in the target population 
estimated to have a particular characteristic. 
Previous studies done at this centre reported a 
prevalence rate of 87.8% for intestinal 
parasitosis among adult HIV seropositive 
patients.[19] P therefore was set at 0.878. 
           q=1.0 – p 
           d= degree of accuracy desired, usually 
set at 0.05  
  q therefore will be 1- 0.878= 0.122. 
Based on these formulae, sample size for the 
study was estimated thus: 
    n= (1.96)2*0.878*0.122 / 0.052 
      = 164.6 














Two hundred and fifty test subjects were 
however recruited for the study in order to 
improve the statistical power of the study 
findings. 
 
Purposive sampling was done to select 
participants into the study, selecting 
consecutive patients presenting to the HAART 
clinic for enrolment into care. Included in the 
study were HIV positive individuals yet to 
commence ART while HIV seropositive 
patients who have been commenced on 
HAART and those who have being on 
antimicrobials in the last two (2) weeks prior to 
sample collection were excluded from the 
study. Equal number of apparently healthy age 
and sex matched patients who were HIV 
seronegative and attending the General 
Outpatient Clinic of the hospital were recruited 
as control. Stool and venous blood samples 
were collected from every participant and sent 
to the Medical Microbiology and Parasitology 
department research laboratory.Macroscopic 
and microscopic examinations of the stool 
samples were done while CD4+ count was 
estimated from the blood sample collected. An 
interviewer-administered questionnaire was 
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also completed at recruitment for all 
participants. 
 
Ethical clearance was sought and obtained 
from the Ethical and research committee of 
UITH and a written informed consent was also 
obtained from the participants after carefully 
explaining the concept of the study to them. 
Permission was equally obtained from the 
Management Science for Health, Nigeria via 
the officer in charge of the UITH HAART clinic, 




Faecal suspension was sieved through a 
disposable paper funnel into a 15 ml conical 
centrifuge tube. 0.85% saline was added 
through the debris on the gauze to bring the 
volume in the centrifuge tube to 15 ml. 
Suspension was centrifuged at 500 × g for 10 
minutes, supernatant decanted and  10 ml of 
10% formalin added to the sediment and 
mixed thoroughly with wooden applicator 
sticks. 4 ml of ethyl acetate added and 
suspension centrifuged at 500 × g for 10 
minutes. The top layers of supernatant were 
decanted and with the use of a cotton-tipped 
applicator, debris from sides of the centrifuge 
tube was removed. Several drops of 10% 
formalin to re-suspend the concentrated 
specimen was added.[37] 
 
Stool wet preparation 
A small amount of the stool specimen was 
placed on a microscope slide and a drop or 
two of saline was added to the specimen and 
mixed. A cover slip was placed on mixture and 
examined under the light microscope at 40x 
magnification.[38] 
 
Modified Ziehl Neelsen stain 
Faecal smears is made from the concentration 
deposit, allowed to air dry, fixed in methanol 
for 3 minutes, stained with strong carbol 
fuchsin for 15-20 minutes and rinse thoroughly 
in tap water. Decolourisation in acid alcohol 
(1% HCl in methanol) for 15-20 seconds was 
done, rinsed thoroughly in tap water, 
counterstained with methylene blue for 30-60 
seconds and rinsed thoroughly and air dry. 
Examination using x40 and x100 objectives 
using light microscopy.[39] 
 
CD4+ count estimation 
The CD4 + cell count was performed using the 
CyFlow® SL (PARTEC, Berlin, Germany) 
counter, a portable desktop flow cytometer 
which uses fluorescent-labelled anti CD4+ 
monoclonal antibodies to capture CD4+ cells 




Clinical findings and laboratory results were 
recorded in the study questionnaire and 
analyzed using the Statistical Package for 
Social Sciences (SPSS), version 19. Results 
were presented in tabular forms and figures as 
found applicable. Categorical variables were 
compared by Chi square test and continuous 
variables were described by means ± SD and 
compared by the Student’s T-test. Statistical 
significance was tested at predetermined p-
value of <0.05. Other statistical tests used 
were Spearman Correlation, a non-parametric 
test that measures the strength of association 
between two ranked variables. Results are 





Diarrhoea was present in 200 out of the 
sampled 500 participants, 118 of which were 
among the HIV positive test group and the 
remaining 82 were among the HIV negative 
control group (table 1).Presence of parasite(s) 
was demonstrated in 79(82.3%) of the test 
participants with diarrhoea and 17(17.7%) of 
the control participants who presented with 
diarrhoea (table 1). Of the 118 HIV positive 
with diarrhoea, 83(70.3%) had a CD4 of <200 
cells/µl and 35(29.7%) had a CD4 of 200-
500cells/µl. 
 
The identified ova of parasites in both groups 
at varying frequencies, were 
Ascarislumbricoides, Balantidium coli, 
Entamoeba histolytica, Schistosoma mansoni, 
Hookworm, Strongyloides stercoralis and 
oocyst of the coccidian parasites (table 2). Of 
the 79 with parasite, 60 had a single species of 
parasite (single parasitosis), while the 
remaining 19 had more than one species of 
parasite present (multiple parasitosis) (table 
3). Likely causes of diarrhoea were examined 
and  majority of the participants (173 test; 216 
of control) source their water from borehole, 63 
of test and 108 of control from tap water, 50 of 
test and 85 of control from well water, while 14 
of test and 18 of control source from stream. 
Concerning their hygienic practices, 174 of the 
test and 231 of the control wash fruits before 
eating, 194 of the test and 239 of the control 
wash hands after defecating, and 187 of the 
test and 243 of the control had modern toilet 
facilities in their homes (figure 1). 
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Table 1: Prevalence of diarrhoea and intestinal parasitosis 
 
 HIV POSITIVE 
   N (%) 
HIV NEGATIVE
    N (%) 
ᵪ
2 p-VALUE 
Diarrhoea (n = 500)     
     Yes  118 (47.2) 82 (32.8)   
     No 132 (52.8) 168 (67.2) 10.8 0.001 
 
Patients with Diarrhoea (n = 200) 
    
     Parasite present 79 (82.3) 17 (17.7)   
     Parasite absent 39 (37.5) 65 (62.5) 41.4 0.001 
 
Patients without diarrhoea (n = 300) 
    
     Parasite present 73 (57.5) 54 (42.5)   















Ascarislumbricoides 26 (10.4) 15 (6.0) 2.951 0.086 
Balatidium coli 0 (0.0) 1 (0.4) 0.000 1.000Y 
Entamoebahistolytica 0 (0.0) 1 (0.4) 0.000 1.000Y 
Fasciolabuski 0 (0.0) 1 (0.4) 0.000 1.000Y 
Hook worm 9 (3.6) 6 (2.4) 0.600 0.439 
Schistosomamansoni 0 (0.0) 1 (0.4) 0.000 1.000Y 
Strongyloidesstercoralis 5 (2.0) 0 (0.0) 3.200 0.074Y 
Coccidian 139 (55.6) 17 (6.8) 95.410 0.001* 
Cryptosporidium 84 (33.6) 11 (4.4) 56.095 <0.001* 
Cyclospora 52 (20.8) 5 (2.0) 38.754 <0.001* 
Isospora 3 (1.2) 1 (0.4) 0.250 0.617Y 
No parasite 98 (39.2) 209 (83.6) 40.134 <0.001* 
Multiple parasites present in some patients; ᵪ2: Chi square; Y: Yates’ chi square (when 20% of 
expected count is less than 5); * P-value less than 0.05 (i.e. statistically significant) 
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Figure 1: Source of water 
 
 
Table 3: Relationship between parasite number and diarrhoea in HIV patients
 
 
Relating hygiene practices and source of water 
in respondents to the likelihood of presenting 
with diarrhoea, it was noted that 46.6% had 
diarrhoea despite washing fruits and 
vegetables before eating, 49% had diarrh
despite washing hands after 
46% had toilet facilities in their homes. 
Concerning their source of water, 71.4% of 
those with diarrhoea source their water from 
stream, 62% of them from well, 60.3% from 
tap borne water and 50.9% from borehole 
(tables 4 and 5). 
 
A multivariate analysis was done using 
Forward Binary logistic regression in order to 
determine the predictors of diarrh
patients. The model that best predicts 
presence of diarrhoea and its variables are 
shown in table 6. The model correctly predicts 
71.0% cases of presence of diarrhea in the 
study participants. Variables excluded by the 










   None 39 (33.1)
   Single 60 (50.8)
   Multiple  19 (16.1)
Total 118 (100.0)








oea in HIV 
vegetables before eating, sources of water 




Diarrhoea is a common presenting 
in HIV-infected patients
aetiological agents include both opportunistic 
agents that consistently cause severe and 
chronic gastrointestinal disease and non
opportunistic agents that usually cause acute 
treatable diarrhoeal illness.
parasitic infection is common in the tropics. 
The prevalence of diarrhoea in HIV positives 
reported in this study is 47.2%. Similar to what 
was reported by Haileeyesus
HIV infection is a risk factor for 
Cryptosporidium and other intestinal parasites 
infections and diarrhoea
revealed a lower prevalence of diarrhoea
causing pathogens and 
HIV patients on ART.[42] 
tap well stream
 
 No Total 
 59 (44.7) 98 (39.2) 
 62 (47.0) 122 (48.8) 
 11 (8.3) 30 (12.0) 





. The infectious 
-
[41] Gastrointestinal 
 et al. in Ethiopia, 
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Table 4: Relationship between hygiene practice, source of water and diarrhoea in HIV patients 
 
 Diarrhoea   
Hygiene practices Yes No Total χ2 p-value 
Wash fruit and vegetables before eating      
        Yes 81 (46.6) 93 (53.4) 174 (100.0) 3.397 0.065 
         No 20 (64.5) 11 (35.5) 31 (100.0)   
Wash hands after defecating      
        Yes 95 (49.0) 99 (51.0) 194 (100.0) 0.130 0.719 
         No 6 (54.5) 5 (45.5) 11 (100.0)   
Toilet facility available at home      
        Yes 86 (46.0) 101 (54.0) 187 (100.0) 11.126 0.001* 
         No 15 (88.2) 2 (11.8) 17 (100.0)   
Source of water      
Stream      
        Yes 10 (71.4) 4 (28.6) 14 (100.0) 2.638 0.104 
         No 90 (48.9) 94 (51.1) 184 (100.0)   
Well      
        Yes 31 (62.0) 19 (30.8) 50 (100.0) 3.536 0.060 
         No 69 (46.6) 79 (53.4) 148 (100.0)   
Tap      
        Yes 38 (60.3) 25 (39.7) 63 (100.0) 3.559 0.059 
         No 62 (45.9) 73 (54.1) 135 (100.0)   
Borehole      
        Yes 88 (50.9) 85 (49.1) 173 (100.0) 0.072 0.789 
         No 12 (48.0) 13 (52.0) 25 (100.0)   
χ
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Table 5: Relationship between hygiene practice, source of water and diarrhoea in control group 
 
 Diarrhoea   
Hygiene practices Yes No Total χ2 p-value 
Wash fruit and vegetables before eating      
        Yes 77 (33.3) 154 (66.7) 231 (100.0) 0.392 0.531 
         No 5 (26.3) 14 (73.7) 19 (100.0)   
Wash hands after defecating      
        Yes 77 (32.2) 162 (67.8) 239 (100.0) 1.631Y 0.202 
         No 2 (100.0) 0 (0.0) 2 (100.0)   
Toilet facility available at home      
        Yes 78 (32.1) 165 (67.9) 243 (100.0) 1.628Y 0.202 
         No 3 (3.7) 1 (0.6) 4 (100.0)   
Source of water      
Stream      
        Yes 6 (33.3) 12 66.7) 18 (100.0) 0.003 0.960 
         No 75 (32.8) 154 (67.2) 229 (100.0)   
Well      
        Yes 25 (29.4) 60 (70.6) 85 (100.0) 0.962 0.327 
         No 57 (35.6) 103 (64.4) 160 (100.0)   
Tap      
        Yes 39 (36.1) 69 (63.9) 108 (100.0) 0.682 0.409 
         No 41 (31.1) 91 (68.9) 132 (100.0)   
Borehole      
        Yes 73 (33.8) 143 (66.2) 216 (100.0) 0.009 0.924 
         No 8 (34.8) 15 (65.2) 23 (100.0)   
χ




Table 6: Predictors of diarrhoea in HIV patients 
 
Variables  B p-value OR 95% C.I 
Lower Upper 
CD 4 count -0.005 <0.001* 0.995 0.993 0.997 
Washing of hands after defecating  -2.237 0.076 0.107 0.009 1.261 
Presence of toilet facility -3.225 0.005* 0.040 0.004 0.380 
B: Coefficient of Binary logistic regression; OR: Odds ratio; C.I: Confidence Interval; *: p value <0.05, R2: 
0.254. Predictive value: 71.0%. χ 2:40.728; p: <0.001 
Variables excluded by the model: Viral load, Washing of fruits and vegetables before eating, Sources of water 
(Stream, Well, Borehole and Tap) 
 
 
In this study, the prevalence of Coccidian 
parasitic infection in the HIV positive patients, 
is 55.6%, the highest and statistically 
significant compared with the other parasites 
(p= 0.001). This is similar to the report of 
Smith et al. in India where 38 out of the 113 
HIV positive stool samples were found to have 
intestinal parasites present, 29 (76.3%) of 
which are coccidian parasites alone or with 
other parasites.[43] Coccidian parasite is an 
opportunistic infection common in HIV 
patients, though can cause self-limiting 
intestinal infection in immunocompetent hosts 
too. Infection in the immunocompromised is 
more severe, probably because the immune 
system which reduces the formation of type 1 
merozoites as well as the number of thin-
walled oocysts which initiates an infection is 
deficient in the HIV infected.[44]Of the coccidian 
parasites detected, Cryptosporidium was 
detected in 33.6% of the HIV positive patients, 
cyclospora in 20.8% and isospora in 1.2% of 
them. Looking at the spectrum of parasites 
seen, there was no statistically significant 
difference between subjects and control when 
protozoa parasites are concerned (p>0.05) 
with the exception of the coccidian parasites 
whose prevalence was significantly different 
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between test and control (p=0.001). This is in 
keeping with previous studies done at UITH 
Ilorin. The findings of Erhabor and Obunge in 
Niger Delta region of Nigeria is similar to this 
also, where they reported cryptosporidiosis to 
be significantly higher in the HIV positive with 
diarrhoea than their HIV negative 
counterpart.[45] Diarrhoea was common and 
most strongly associated in patients with  
CD4+ cell counts less than 200 (70.3%). In 
33.1% of the patients with diarrhea there were 
no parasites identified while some of the 
diarrheal episodes were undiagnosed. This 
suggests that unidentified pathogens or 
primary HIV enteropathy are major causes of 
diarrhoea in the population.[46,47] In keeping 
with these findings is the report of Suresh et al. 
in Venezuela and Weber et al. in Swiss where 
intestinal infections were diagnosed in less 
than 50% of chronic diarrhoeal episodes.[46,47] 
In addition to not isolating any pathogen in the 
majority of the samples, wherever pathogens 
were found, protozoan infections dominated 
over the bacterial causes.[46,47] Needless to say 
that all aetiological agents cannot be easily 
diagnosed in Africa on routine basis because 
of limited diagnostic facilities and trained 
personnel coupled with the fact that diagnosis 
could  require high tech instrument and 
molecular studies.[20] 
 
There is a negative association between 
source of water and hygiene practices, and the 
presence of diarrhoea in HIV positive 
individuals and a rather strong positive 
association between CD4 levels and presence 
of diarrhoea. This is a pointer to the possibility 
that diarrhoea in the HIV positive is a function 
of their depressed immune status, more than 
their lifestyle practices. This is in deviant to 
what Suresh and Weber reported which is a 
strong negative association between diarrhoea 
and CD4 count.[46,47] 
 
Progressive immunosuppression is associated 
with a rise in the prevalence of GI features. In 
HIV-infected patients in the groups CD4+ > 
500 cells/µL, 200 cells/µL -500 cells/µL and in 
the AIDS patients CD4+ < 200 cells/µL, 
diarrhoea was 0, 29.7 and 70.3%. Diarrhoea 
was also found to be significantly present in 
HIV positives compared with HIV negative 
controls (p=0.001); intestinal parasitosis was 
also significantly associated with HIV 
seropositivity irrespective of whether patient is 
diarrhoeic or not (p=0.001). This is in 
agreement with findings in Kano where it was 
reported that diarrhoea is a frequent 
presenting complaint in HIV positives, 
especially at CD4+ count of <200cells/µl. This 
finding is however not surprising for 
gastrointestinal disease, particularly diarrhoea, 
which is the commonest clinical presentation 
of HIV/AIDS in Africa and other developing 
countries, occurring in 90-100% of patients 
with HIV infection.[48] It has also been noted 
that due to down regulation of the immune 
system in the HIV infected, opportunistic 
infections, parasitic and non-parasitic, occur 
more commonly in the HIV infected.[49] 
 
It was also observed that the presence of GI 
parasites predisposed to development of 
diarrhoea in HIV infected patients. The 
presence of single (one specie) or multiple 
(more than one species of parasite) 
parasitoses was found not to be statistically 
significant.   
 
Several environmental and socioeconomic 
factors have been identified to predispose an 
individual to diarrhoea. They include poor 
sanitary conditions, unhygienic practices, 
absence of portable water, poor housing and 
poverty.[50,51,52]In this study however, these 
factors did not significantly influence the 
presence of diarrhoea in HIV positives 
compared to their HIV negative controls. CD4 
count was the only variable seen to influence 
the development of diarrhoea. This is a pointer 
to the fact that the presence and persistence 
of gastrointestinal parasites in the HIV infected 
and the subsequent passage of watery stool 
that results is a function of the suppressed or 
deficient immune system of the host much 
more than the physical and socioeconomic 




Diarrhoea in HIV occurs irrespective of the 
geographical location of the individual, the 
socioeconomic status of the individual, the 
daily activities and lifestyle but rather it is a 
function of the immune status of the individual. 
The more immunosuppressed the individual is, 
the greater the likelihood of presenting with 
diarrhoea associated with parasitic infection. 
This might be due to marked reduction in both 
the peripheral and the GI CD4 cells quantity as 
well as due to alteration in structure and 





1. Screening for parasitic 
infection should form part of the baseline 
investigations when enrolling clients into HIV 
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care program and the specific investigation 
should include stool for ova of parasite. 
2. Antiparasitic agents should be 
included when treating treatment naïve HIV 
infected patients with diarrhoea. 
3. Antiparasitic agents should be 
commenced prophylactically at CD4+ T cell 
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